Amitraz; Metaflumizone
10 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
1
Deaths Reported
1000.0%
Death Rate
Active Ingredients
Amitraz; Metaflumizone
Administration Routes
TopicalOral
Species Affected
Dog 10
Most Affected Breeds
Collie - Border 2
Coonhound - Bluetick 1
Catahoula Leopard Dog 1
Mastiff 1
Deutsche Dogge, Great Dane 1
Terrier - Bull - American Pit 1
Pug 1
Spitz - German Pomeranian 1
Shih Tzu 1
Most Reported Reactions
Lack of efficacy (ectoparasite) - Demodex 4
Skin lesion NOS 3
Other abnormal test result NOS 3
Pruritus 3
Lethargy (see also Central nervous system depression in 'Neurological') 3
Oedema of the extremities (see also other SOCs for most applicable oedema) 2
Erythema (for urticaria see Immune SOC) 2
Pyoderma 2
Hyperphosphataemia 2
Elevated serum alkaline phosphatase (SAP) 2
SKIN SCRAPING ABNORMAL 2
Seizure NOS 2
Outcome Breakdown
Ongoing
8 (80.0%)
Outcome Unknown
1 (10.0%)
Euthanized
1 (10.0%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.